No. 1 online shop for research peptides in Europe

Pre-Filled Pen

Research use only

YK-11 (Myostatin) 35mg / 1.5mL

€97.00

VAT included. Shipping calculated at checkout.

Notify me when it's back

Leave your email and we'll let you know as soon as this is available again.

We'll only use your email for this one message. Unsubscribe anytime.

  • ≥99% purity
  • HPLC & LC-MS analysed
  • Stabilised formula
  • The world's first brand of peptides in a pen

Secure delivery

Secure delivery with FedEx within 1–2 business days after payment confirmation

Payment methods

  • Bank transfer
How the pen worksVideo in English

What Is YK-11?

YK-11 is a synthetic compound classified as a Selective Androgen Receptor Modulator (SARM), distinguished by a steroidal structure derived from dihydrotestosterone (DHT). It was developed as a research tool to explore androgen receptor activity in muscle cell models, and it is notable for combining partial androgen receptor agonism with an influence on the myostatin pathway. This dual profile differentiates it from other SARMs and has made it a subject of scientific interest in molecular biology and muscle regulation research.

How Does YK-11 Work?

YK-11 binds to androgen receptors and, in cell culture studies, activated gene pathways associated with myogenic differentiation. A key reported feature of its mechanism is increased expression of follistatin, an endogenous protein that antagonises myostatin. Myostatin is a major negative regulator of skeletal muscle growth. In a 2013 study in C2C12 myoblasts (Kanno et al., Biological and Pharmaceutical Bulletin), YK-11 induced follistatin expression and myogenic differentiation, and the effect was attenuated by an anti-follistatin antibody. These findings make it a compound of interest for studies of androgen receptor signalling and muscle cell physiology.

Research Findings on YK-11

YK-11 has generated interest in research communities because of several effects observed in laboratory models. Reported findings include:

  • Partial agonist activity at the androgen receptor in cell-based assays;
  • Increased follistatin expression and consequent modulation of myostatin signalling in myoblast cultures;
  • Induction of myogenic differentiation markers (such as MyoD, Myf5 and myogenin) in vitro;
  • Reported effects on osteoblast proliferation in cell culture studies;
  • A gene-selective pattern of androgen receptor activation that is still being characterised.

These effects remain under investigation through laboratory analyses aimed at a deeper understanding of the molecular mechanisms involved in muscle regulation. Human data are lacking.

YK-11 vs Other SARMs

YK-11 differs from other Selective Androgen Receptor Modulators (SARMs) in its DHT-derived steroidal structure and in its reported ability to influence follistatin, an endogenous myostatin inhibitor. This additional mechanism places it in a distinct category compared with non-steroidal SARMs such as Ostarine (MK-2866), RAD-140 and S23.

Ostarine has been studied more extensively, including in clinical trials, whereas YK-11 has so far been characterised mainly in cell culture and a limited number of animal experiments.

RAD-140 is a non-steroidal SARM investigated for its androgen receptor selectivity; the follistatin-related mechanism described for YK-11 has not been reported for RAD-140, which makes the two compounds useful for comparative studies of myostatin pathway involvement.

S23 is a high-affinity non-steroidal SARM that has been studied in animal models, including for its suppressive effects on the hypothalamic-pituitary-gonadal axis. YK-11 represents a structurally different approach to androgen receptor modulation.

Because of its distinct mechanism, YK-11 is used in laboratory research where the interplay between androgen receptor signalling and myostatin regulation is being investigated.

Specifications and Storage

Content: 35 mg YK-11 in 1.5 ml.

Total pen content: 150 units.

Store refrigerated (2–8 °C) and protected from light. For laboratory research use only; not for human consumption.

Safety Profile of YK-11

The safety profile of YK-11 has not been established. Published data are limited to preclinical work, and the effects noted in the literature for androgen receptor ligands of this type include:

  • Suppression of endogenous testosterone production;
  • Androgenic effects;
  • An absence of data on long-term safety.

YK-11 is supplied strictly for research use only.

Blog

From the blog

More from SARMs

Shopping information

Delivery

Delivered within 1–2 business days after your payment has been confirmed.

  • Shipped with FedEx
  • Shipping costs: €8.90
Shipping policy

Payment

  • Bank transfer

Pay securely by bank transfer. Your order is dispatched as soon as your payment has been confirmed.

For research use only

For scientific, laboratory, analytical and research use only, including as a reference standard in HPLC analyses – not for use in humans or animals.

Read more

All products are intended solely and exclusively for scientific, laboratory, analytical and research purposes, including use as reference standards in HPLC analyses. They are not intended for use in humans or animals, including for the diagnosis, treatment or prevention of disease, and are not approved medicinal products.

Contact & service

Questions about an order, delivery or a product? Our customer service team is happy to help.

ContactFAQ